Skip to main content
. 2011 Mar 14;13(3):465–469. doi: 10.1038/aja.2010.164

Table 2. IVF and embryo transfer outcomes for HBV-positive and HBV-negative groups.

Variable Positive (n=587) Negative (n=587) P value
Age of wives (year) 31.4±4.9 31.4±4.9 NS
Female BMI (kg m−2) 22.0±3.2 22.0±3.3 NS
Duration of infertility (year) 4.9±3.4 4.7±3.3 NS
Times of IVF–ET/ICSI–ET (cycle) 1.1±0.4 1.1±0.4 NS
Primary infertility (n, %) 181 (30.8) 183 (31.2) NS
Distribution of infertile factors (n, %)      
 Total number of husbands with sperm problems 415 (71.3) 379 (65.1) 0.025
 Total number of wives with tubal blockage 503 (85.7) 485 (82.6) NS
 Total number of wives with ovulation failure 14 (2.4) 20 (3.4) NS
 Total number of wives with endometriosis 77 (13.1) 62 (10.6) NS
 Total number of couples with unexplained infertility 14 (2.4) 13 (2.2) NS
Duration of stimulation (d) 9.6±2.2 9.7±2.1 NS
Total dose of gonadotropin used (IU) 2670±1085 2659±1056 NS
Serum E2 levels on day of hCG injection (pmol l−1) 1 1669±7024 1 2161±7634 NS
No. of retrieved oocytes 12.5±6.4 12.6±6.4 NS
No. of embryos transferred in cycles by ET 2.1±0.5 2.1±0.5 NS
2PN fertilisation rate (%) 4508/7144 (63.1) 4803/7623 (63.0) NS
High-grade embryo rate (%) 2757/4633 (59.5) 2907/4943 (58.8) NS
Implantation rate (%) 284/1140 (24.9) 296/1108 (26.7) NS
Clinical pregnancy rate (%) 217/535 (40.5) 210/521 (40.3) NS
Cancellation rate (n, %) 52 (8.9) 66 (11.2) NS

Values are presented as mean±s.d.

Abbreviations: BMI, body mass index; E2, estradiol; ET, embryo transfer; HBV, hepatitis B virus; hCG, human chorionic gonadotrophin; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilisation; NS, not significant; 2PN, two-pronuclear.